Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Hers vs TeleZen MD

TeleZen MD costs $1 less a month, and both sell semaglutide and tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Hers logo

Hers

6.6
★★★☆☆3.3/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit Hers →
VS
TeleZen MD logo

TeleZen MD

5.8
★★★☆☆2.9/5

Best for: compounded semaglutide at $198/month

Visit TeleZen MD →

If you are choosing between Hers and TeleZen MD, the first difference is cost: TeleZen MD is $1 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Hers leads our six-part score, 6.6 to 5.8. One of the two has an FDA warning letter on record, covered below.

Hers vs TeleZen MD price

TeleZen MD is the cheaper way in: $198 a month against $199 a month at Hers. That is $1 less each month (1% lower), or about $12 over a year of treatment.

Drug by drug: Semaglutide is cheaper at TeleZen MD ($198 a month vs $199 a month); tirzepatide is cheaper at TeleZen MD ($298 a month vs $299 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Hers prices compounded injections and brand-name pens, while TeleZen MD prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, Hers is the only one of the two with a brand-name price.

Where each one treats patients

Hers lists 50 states, and TeleZen MD does not publish where it ships.

Pricing

Hers

StartingCompounded
$199/mo
semaglutide
StartingBrand-name
$299/mo
tirzepatide

Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)

TeleZen MD

Compounded GLP-1 plan, standard monthly rateCompounded
$198/mo
semaglutide

$148 first month, $198/month after. Multi-month plans (paid in full): quarterly $166/mo ($498), semi-annual $149/mo ($898), annual $133/mo ($1598). Prices are estimated monthly-equivalent of the 3-/6-month plans.

Compounded GLP-1 + GIP plan, standard monthly rateCompounded
$298/mo
tirzepatide

$248 first month, $298/month after. Multi-month plans (paid in full): quarterly $249/mo ($748), semi-annual $233/mo ($1398), annual $216/mo ($2598).

What each price covers

Both prices cover the medication itself.

TeleZen MD's price also covers the clinician visit and shipping, which Hers does not claim.

Hers is silent on shipping and lab work.

TeleZen MD is silent on lab work and coaching.

Hers

Covered by the monthly price

Medication

In the price

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Not stated

Coaching

Charged on top

TeleZen MD

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Hers scores 6.6 and TeleZen MD 5.8 out of 10.

Hers is stronger on user experience (8.0 vs 2.5), trust & safety (5.5 vs 4.0) and accessibility (10.0 vs 5.0).

TeleZen MD is stronger on value (4.5 vs 3.0) and support (7.0 vs 3.0).

Effectiveness is within half a point.

How we score

Hers

6.6/10

Overall

TeleZen MD

5.8/10

Value25%

3.0A
vs
B
4.5

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
2.5

Trust & Safety15%

5.5A
vs
B
4.0

Accessibility10%

10.0A
vs
B
5.0

Support10%

3.0A
vs
B
7.0

FDA warning letters

The FDA sent Hers a warning letter dated September 9, 2025 (letter 716825), and it is still open.

TeleZen MD has no FDA warning letter on record with us.

Features & Coverage

FeatureHersTeleZen MD
Starting Price$199/mo✓$198/mo
Features2 features✓3 features
States Available50Not disclosed
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning Letters1 letter✓None

About Hers

Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.

Read our full Hers review →

About TeleZen MD

Steady-state monthly pricing never appears on the marketing home page. TeleZen MD runs entirely online, 100% so by its own description, and routes GLP-1 therapy through pharmacies inside the U.S. that are FDA-registered. Coverage is claimed for all 50 states, with the caveat, in the provider's words, 'subject to medical eligibility and state regulations.' Anyone ordering for the first time is offered $100 off with the code WELCOME100.

Read our full TeleZen MD review →

Pros & Cons

Hers

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication
  • Serves all 50 states

Watch-outs

  • Not included in the monthly price: clinician visits, coaching
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued Hers a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

TeleZen MD

What we like

  • Semaglutide costs $198 a month, close to the $185 median for compounded semaglutide across the sellers we compare
  • The monthly price includes the medication, clinician visits and shipping
  • We found no FDA warning letters issued to TeleZen MD
  • A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake

Watch-outs

  • Tirzepatide costs $298 a month, 19% above the $250 median for compounded tirzepatide across the sellers we compare
  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Hers

Hers wins this one, 6.6 to 5.8, above all for coverage in all 50 states, which most sellers will not confirm. TeleZen MD undercuts it by $1 a month, so if the monthly bill is what decides it, TeleZen MD is the pick. TeleZen MD fits better if compounded semaglutide at $198/month is your priority.

Choose Hers if…

You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.

Choose TeleZen MD if…

You want compounded semaglutide at $198/month and an opening price near $198 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.4

Strut Health

Semaglutide at $99/month, 48% below the typical price

8.4

Enhance MD

Knowing which pharmacy fills the vial: it names Tru Meds Rx

6.1

DudeMeds

Compounded semaglutide at $175/month

Hers vs TeleZen MD: FAQ

TeleZen MD. It starts at $198 a month; Hers starts at $199 a month, $1 more per month.
Yes, both sell semaglutide and tirzepatide.
Hers lists 50 states; TeleZen MD does not publish where it ships. Confirm your state before paying.
Both include the medication itself. Only TeleZen MD includes the clinician visit and shipping.
Hers has an open FDA warning letter from September 9, 2025. TeleZen MD has none.
No. Neither Hers nor TeleZen MD pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.